1. Home
  2. MTEM

as 11-15-2024 12:37pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

Founded: 2001 Country:
United States
United States
Employees: N/A City: AUSTIN
Market Cap: 9.7M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 15.9M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.79 EPS Growth: N/A
52 Week Low/High: $0.30 - $5.45 Next Earning Date: 11-19-2024
Revenue: $25,470,000 Revenue Growth: -49.41%
Revenue Growth (this year): -78.05% Revenue Growth (next year): -89.81%

MTEM Daily Stock ML Predictions

Share on Social Networks: